<DOC>
	<DOC>NCT00660569</DOC>
	<brief_summary>The purpose of this study is to identify the potential issues during short and mid term utilization of Pulmicort hydro fluoroaklane (HFA) pressurized metered-dose inhaler (pMDI)and describe associated factors.</brief_summary>
	<brief_title>Utilization Patterns of Pulmicort in Real Life Practice</brief_title>
	<detailed_description />
	<mesh_term>Budesonide</mesh_term>
	<criteria>Asthmatic patients with a diagnose of at least 12 months of duration before study inclusion Patients previously treated with Pulmicort CFC who have changed their treatment to Pulmicort HFA Disability that, from investigator point of view, prevent from complying the follow up schedule To have participated in any clinical study in the past 6 months</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>asthma treatment</keyword>
	<keyword>utilization</keyword>
	<keyword>real life practice</keyword>
</DOC>